Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New app aims to ease mental struggles after ICU stays

NCT ID NCT06504979

Symptom relief Sponsor: Corporacion Parc Tauli Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a digital platform called ICURA to help ICU survivors and their families manage emotional, cognitive, and physical problems that often occur after intensive care. About 360 adults who were in the ICU will be randomly assigned to use the app or receive standard follow-up care. The goal is to see if the app improves quality of life and daily functioning over 12 months.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
digital telehealth platform (ICURA)
What this could lead to
If successful, this could provide a practical, scalable way to improve mental health and daily functioning for ICU survivors and their families during the first year after discharge.
What could go wrong
This is an observational study, not a treatment trial, so it cannot prove cause and effect. The digital tool may not work for everyone, and results may vary based on individual circumstances.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 360 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2024

Expected to finish

Jan 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 89 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adult (≥18 years old) critically ill patients admitted to the ICU with or without need of invasive mechanical ventilation (IMV). Exclusion Criteria: * Non-authorization of the relatives and/or patient to inclusion in the study; neurocritical ICU patients. * Severe neurological pathology (including dementia or focal brain damage with functional and cognitive impairment) prior to admission to the ICU. * Severe psychiatric pathology (schizophrenia, bipolar disorder, major depressive disorder) * Intellectual disability (IQ \<80). * Patients who develop secondary complications (infections, stroke, TBI or any non-transient acquired brain damage) after ICU discharge, that may compromise the results of the emotional and neuropsychological evaluation during the recovery phase * Moderate-severe cognitive impairment (Short-IQCODE \>85) that impair ICU patients an independent participation in the telematic follow up and accompaniment program * Readmission to ICU within 12 months after discharge from ICU * Idiomatic barrier (non spanish and/or catalan speaker) * Patients with life expectancy \<1 year or not subsidiaries of active treatment measures.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Icu families are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

postintensive care syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Icu families Icu survivors Post intensive care syndrome

Contacts and locations

Locations

  • Institut d'Investigació i Innovació Parc Taulí

    Sabadell, Barcelona, 08208, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.